Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00679848 · ClinicalTrials.gov registry record · Phase 1
Transoral Gastric Volume Reduction as an Intervention for Weight Management
A Phase 1 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00679848 is a Phase 1 study that has completed, run by C. R. Bard. The registered enrollment target is 18 participants.
The verdict
NCT00679848, a Phase 1 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, technical feasibility, and initial effectiveness (i.e., weight loss primarily measured as percent excess weight loss) of TGVR performed using the Bard RESTORe Suturing System
Interventions
- DEVICE RS2 (RESTORe Suturing System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00679848
The ClinicalTrials.gov registry entry for NCT00679848 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RS2 (RESTORe Suturing System) is the first listed.
NCT00679848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00679848 about?
NCT00679848 is a clinical study titled "Transoral Gastric Volume Reduction as an Intervention for Weight Management". The purpose of this study is to evaluate the safety, technical feasibility, and initial effectiveness (i.e., weight loss primarily measured as percent excess weight loss) of TGVR performed using the Bard RESTORe Suturing System
What is the current status of trial NCT00679848?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2008-05. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00679848?
The interventions under investigation include: RS2 (RESTORe Suturing System) (DEVICE).
Who is sponsoring clinical trial NCT00679848?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.